OXi4503
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for OXi4503, covering 2011-08-23 to 2018-06-04. Get the full timeline:
Most recent: Clinical Trial Update: Dose Escalation of OXi4503 as Single Agent and Combination With Cytarabine w/Subsequent Ph 2 Cohorts for AML and MDS [Phase 1, Phase 2]